Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Arcus Biosciences (RCUS) Other Gross PP&E Adjustments (2017 - 2025)

Arcus Biosciences (RCUS) has 8 years of Other Gross PP&E Adjustments data on record, last reported at $64.0 million in Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments changed N/A year-over-year to $64.0 million; the TTM value through Dec 2025 reached $64.0 million, changed N/A, while the annual FY2025 figure was $64.0 million, N/A changed from the prior year.
  • Other Gross PP&E Adjustments reached $64.0 million in Q4 2025 per RCUS's latest filing, up from $61.0 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $64.0 million in Q4 2025 and bottomed at -$104.3 million in Q2 2022.
  • Average Other Gross PP&E Adjustments over 4 years is -$29.3 million, with a median of -$36.5 million recorded in 2021.
  • Peak YoY movement for Other Gross PP&E Adjustments: crashed 8333.87% in 2021, then soared 164.65% in 2022.
  • A 4-year view of Other Gross PP&E Adjustments shows it stood at -$65.0 million in 2021, then skyrocketed by 164.65% to $42.0 million in 2022, then soared by 45.24% to $61.0 million in 2023, then rose by 4.92% to $64.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $64.0 million in Q4 2025, $61.0 million in Q4 2023, and $42.0 million in Q4 2022.